Search results
Study: Ozempic boosts health, survival of patients with kidney disease, Type 2 diabetes
United Press International via Yahoo News· 4 hours agoOzempic significantly reduces the risk of severe kidney events, heart problems and death from any...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters via Yahoo News· 13 hours agoNovo Nordisk's Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
Reuters via AOL· 3 hours agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an...
Ozempic Slows Kidney Disease, Novo Nordisk Study Finds
The Wall Street Journal· 9 hours agoNovo Nordisk’s Ozempic drug slows the progression of chronic kidney disease and cuts the risk of...
Study says 72 hours not long enough before removing life support
Deseret News via Yahoo News· 4 hours agoA new study suggests that waiting longer than 72 hours to remove life support in patients with...
Study investigates systemic thrombolysis in patients with liver cirrhosis
Medical Xpress· 5 hours agoThe prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute decompensated ...
Semaglutide significantly reduces risk of complications in patients with type 2 diabetes, study...
Medical Xpress· 7 hours agoA pioneering study has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in < ...
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
Investor's Business Daily· 3 hours agoThe Netherlands-based biotech paired its drug, petosemtamab, with Merck's cancer blockbuster,...
Ozempic can also help with chronic kidney disease, Novo Nordisk-funded study finds
Quartz· 6 hours ago...A weekly, one-milligram injection of semaglutide, the active ingredient in Ozempic and the weight...
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 11 hours agoVerastem’s trial, named RAMP 205, is a single-arm study evaluating avutometinib plus defactinib in...